Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remission Evaluation of Metabolic Interventions in Type 2 Diabetes in Primary Care (REMIT-Prime): An Implementation-effectiveness Study

NCT07665567 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT07665567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07665567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remission Evaluation of Metabolic Interventions in Type 2 Diabetes in Primary Care (REMIT-Prime): An Implementation-effectiveness Study
Lead sponsor
McMaster University
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 11, 2026
Completion date
April 1, 2028
Enrollment
118 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes (t2dm)